Aikaterini Chatzipli, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Amplification | 1 | 2021 | 1062 | 0.580 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.430 |
Why?
|
| Neurofibrosarcoma | 1 | 2023 | 24 | 0.220 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2023 | 190 | 0.200 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2022 | 197 | 0.190 |
Why?
|
| Exodeoxyribonucleases | 1 | 2020 | 176 | 0.170 |
Why?
|
| Mutation | 3 | 2021 | 29717 | 0.160 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 251 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13655 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2023 | 562 | 0.150 |
Why?
|
| Biological Assay | 1 | 2020 | 652 | 0.150 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 974 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1434 | 0.130 |
Why?
|
| Gene Frequency | 1 | 2021 | 3587 | 0.120 |
Why?
|
| Telomere | 1 | 2020 | 909 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 870 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20774 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 2 | 2021 | 2721 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 2186 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2410 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 6754 | 0.090 |
Why?
|
| DNA Damage | 1 | 2020 | 2423 | 0.090 |
Why?
|
| RNA | 1 | 2020 | 2747 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4801 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2187 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8425 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3518 | 0.070 |
Why?
|
| Genomics | 4 | 2023 | 5692 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2019 | 3456 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7716 | 0.060 |
Why?
|
| Neoplasms | 3 | 2022 | 21596 | 0.060 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2022 | 49 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2022 | 195 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9185 | 0.050 |
Why?
|
| Cytosine Deaminase | 1 | 2020 | 68 | 0.050 |
Why?
|
| U937 Cells | 1 | 2020 | 268 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11472 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2020 | 408 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2019 | 206 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 624 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8829 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2019 | 349 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2023 | 4282 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 678 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2020 | 695 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2019 | 627 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 62966 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 16665 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9410 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2303 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1459 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 824 | 0.030 |
Why?
|
| Histones | 1 | 2023 | 2597 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 742088 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3471 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4187 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2935 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1937 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2842 | 0.020 |
Why?
|
| Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
| Female | 3 | 2021 | 379592 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.020 |
Why?
|
| Internet | 1 | 2019 | 3062 | 0.020 |
Why?
|
| Apoptosis | 1 | 2022 | 9715 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15056 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9941 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7901 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13256 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16331 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21719 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 13853 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29010 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 162944 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 213127 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 213712 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|
| Male | 2 | 2020 | 349538 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81045 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85649 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 168561 | 0.000 |
Why?
|